Arcturus Therapeutics Holdings

-$2.00 (-8.52%) Today

$0.00 (0.00%) As of 11:00 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ARCT and other ETFs, options, and stocks.

About ARCT

Arcturus Therapeutics Holdings, Inc. is a clinical-stage mRNA medicines and vaccines company, which focuses on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases. Its products include LUNAR-COV19, LUNAR-FLU, LUNAR-OTC, and LUNAR-CF.

CEO

Joseph E. Payne

Employees

118

Headquarters

San Diego, California

Founded

2013

ARCT Key Statistics

Market cap

Price-Earnings ratio

—

Dividend yield

—

Average volume

609.31K

High today

$24.00

Low today

$21.10

Open price

$23.83

Volume

522.81K

52 Week high

$89.18

52 Week low

$21.02

ARCT News

BenzingaJan 24

Arcturus Therapeutics' COVID-19 Booster Clinical Trial Show Encouraging Neutralizing Antibody Responses

In this article: Arcturus Therapeutics Holdings Inc (NASDAQ: ARCT) has announced updated data Phase 1/2 booster trial of ARCT-154 and ARCT-165, its investigati

Analyst ratings

Buy

50%

Hold

10%

Sell

40%

ARCT Earnings

-$2.15

-$1.43

-$0.72

$0.00

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Q2 FY21

Q3 FY21

Q4 FY21

Estimated

— per share

Actual

Expected Feb 28, After Hours